Robert Paridaens
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
- Bone health and treatments
Papers in
- Oncology 136
- Cancer Treatment and Pharmacology 65
- HER2/EGFR in Cancer Research 38
- Cancer Risks and Factors 13
- Neutropenia and Cancer Infections 12
- Cancer survivorship and care 9
-
- Breast Cancer Treatment Studies 76
- Co-authors
- Martine Piccart (31 shared papers)Hans Wildiers (69 shared papers)Patrick Neven (69 shared papers)Marie-Rose Christiaens (24 shared papers)Aron Goldhirsch (14 shared papers)Beat Thürlimann (11 shared papers)Luc Dirix (16 shared papers)Laura Biganzoli (11 shared papers)
- Journals
- European Journal of Cancer (35 papers)Journal of Clinical Oncology (34 papers)Annals of Oncology (30 papers)Cancer Research (25 papers)Breast Cancer Research and Treatment (20 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Robert Paridaens
298 papers receiving 9.7k citations
Robert Paridaens's Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 2.8k
- Oncology 4.7k
- Genetics 2.5k
- Pulmonary and Respiratory Medicine 1.5k
- Pathology and Forensic Medicine 474
Countries citing papers authored by Robert Paridaens
This map shows the geographic impact of Robert Paridaens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Paridaens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Paridaens more than expected).
Fields of papers citing papers by Robert Paridaens
This network shows the impact of papers produced by Robert Paridaens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Paridaens. The network helps show where Robert Paridaens may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Paridaens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Hit paper breakdown → | 2007 | 697 |
| 2 | 2010 | 392 | |
| 3 | 2000 | 288 | |
| 4 | 2008 | 269 | |
| 5 | 2011 | 265 | |
| 6 | 2008 | 230 | |
| 7 | 1986 | 215 | |
| 8 | 2003 | 172 | |
| 9 | 2008 | 165 | |
| 10 | 2010 | 164 | |
| 11 | 2008 | 148 | |
| 12 | 2004 | 143 | |
| 13 | 2005 | 139 | |
| 14 | 2000 | 139 | |
| 15 | 2009 | 137 | |
| 16 | 1997 | 127 | |
| 17 | 2004 | 118 | |
| 18 | 2008 | 116 | |
| 19 | 2008 | 115 | |
| 20 | 2008 | 107 |
About Robert Paridaens
Robert Paridaens is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 308 papers that have together received 10.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (90 papers), Breast Cancer Treatment Studies (76 papers), Cancer Treatment and Pharmacology (65 papers), HER2/EGFR in Cancer Research (38 papers), Advanced Breast Cancer Therapies (29 papers), Cancer Risks and Factors (13 papers), Neutropenia and Cancer Infections (12 papers) and Cancer survivorship and care (9 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (4.7k citations), Genetics (2.5k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Pathology and Forensic Medicine (474 citations). Robert Paridaens has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Martine Piccart, Hans Wildiers, Patrick Neven, Marie-Rose Christiaens, Aron Goldhirsch, Beat Thürlimann, Luc Dirix, Laura Biganzoli, L. Mauriac and Ignace Vergote. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.